Declerck PJ - Search Results

1

Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1).

Vaughan DE, Declerck PJ, Reilly TM, Park K, Collen D, Fasman GD. Vaughan DE, et al. Among authors: declerck pj. Biochim Biophys Acta. 1993 Oct 6;1202(2):221-9. doi: 10.1016/0167-4838(93)90008-f. Biochim Biophys Acta. 1993. PMID: 8399383

2

Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo.

Vaughan DE, Declerck PJ, Van Houtte E, De Mol M, Collen D. Vaughan DE, et al. Among authors: declerck pj. Thromb Haemost. 1992 Jul 6;68(1):60-3. Thromb Haemost. 1992. PMID: 1514173

3

Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator.

Declerck PJ, De Mol M, Vaughan DE, Collen D. Declerck PJ, et al. J Biol Chem. 1992 Jun 15;267(17):11693-6. J Biol Chem. 1992. PMID: 1601844 Free article.

4

Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.

Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G. Preissner KT, et al. J Biol Chem. 1990 Oct 25;265(30):18490-8. J Biol Chem. 1990. PMID: 1698787 Free article.

5

Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.

Russell ME, Quertermous T, Declerck PJ, Collen D, Haber E, Homcy CJ. Russell ME, et al. Among authors: declerck pj. J Biol Chem. 1990 Feb 15;265(5):2569-75. J Biol Chem. 1990. PMID: 2105930 Free article.

6

Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo.

Vaughan DE, Declerck PJ, Van Houtte E, De Mol M, Collen D. Vaughan DE, et al. Among authors: declerck pj. Circ Res. 1990 Nov;67(5):1281-6. doi: 10.1161/01.res.67.5.1281. Circ Res. 1990. PMID: 2225359

7

Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits.

Vaughan DE, Declerck PJ, De Mol M, Collen D. Vaughan DE, et al. Among authors: declerck pj. J Clin Invest. 1989 Aug;84(2):586-91. doi: 10.1172/JCI114202. J Clin Invest. 1989. PMID: 2503540 Free PMC article.

8

Characterization of the binding of human tissue-type plasminogen activator to platelets.

Vaughan DE, Mendelsohn ME, Declerck PJ, Van Houtte E, Collen D, Loscalzo J. Vaughan DE, et al. Among authors: declerck pj. J Biol Chem. 1989 Sep 25;264(27):15869-74. J Biol Chem. 1989. PMID: 2550424 Free article.

9

Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.

Audenaert AM, Knockaert I, Collen D, Declerck PJ. Audenaert AM, et al. Among authors: declerck pj. J Biol Chem. 1994 Jul 29;269(30):19559-64. J Biol Chem. 1994. PMID: 8034724 Free article.

10

Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).

Lijnen HR, Arza B, Van Hoef B, Collen D, Declerck PJ. Lijnen HR, et al. Among authors: declerck pj. J Biol Chem. 2000 Dec 1;275(48):37645-50. doi: 10.1074/jbc.M006475200. J Biol Chem. 2000. PMID: 10967118 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

268 results

Search Page

Filters